Huawei reveals long-range Ascend chip roadmap — three-year plan includes ambitious provision for in-house HBM with up to 1.6 TB/s bandwidth

Huawei
(Image credit: Shutterstock)

Huawei’s AI silicon roadmap is no longer a state secret. Speaking at the Huawei Connect conference on September 18, rotating chairman Xu Zhijun outlined the company’s first official long-range Ascend chip strategy, with four new parts scheduled across the next three years: Ascend 950PR and 950DT in early 2026, followed by Ascend 960 and 970 in 2027 and 2028, respectively.

Huawei says its upcoming 950PR chip will ship in Q1 next year with in-house HBM designed to compete with the likes of SK hynix and Samsung. That’s a pretty bold claim considering HBM supply and factors like packaging and bandwidth efficiency have arguably become the single biggest constraint on AI accelerator performance at scale.

According to Huawei, the 950PR will feature 128GB of its in-house HBM delivering up to 1.6 TB/s of bandwidth, while the 950DT increases those figures to 144GB and 4 TB/s, but Huawei hasn’t disclosed how its in-house HBM is manufactured, what packaging is used, or which foundry is producing the chip itself.

That hasn’t stopped the company from talking scale, though. Alongside its chip roadmap, Huawei teased new so-called “supernodes” that will house thousands of Ascend chips. The Atlas 950 and 960 systems are positioned as next-gen AI compute clusters that, on paper, rival Nvidia’s GB200 NVL72 configurations in deployment scale, with up to 15,488 Ascend accelerators in a single system. Huawei says Atlas 950 will debut in Q4 this year.

Huawei will need a proven end-to-end platform that can match Nvidia in training, efficiency, and model throughput for its roadmap to succeed. Right now, it doesn’t, and plans alone don’t break bottlenecks.

TOPICS
Luke James
Contributor

Luke James is a freelance writer and journalist.  Although his background is in legal, he has a personal interest in all things tech, especially hardware and microelectronics, and anything regulatory.